Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy

Journal of Hepatology

Volumn 28, Issue 1, 1998, Pages 91-98

  Brites, Dora ^a   Rodrigues, Cecília M P ^a   Oliveira, Nuno ^a   Cardoso, Maria Da Conceição ^b   Graça, Luís M ^b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Cholestasis of pregnancy; Cholic acid; Serum bile acid profile; Ursodeoxycholic acid therapy

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; GLYCINE; LITHOCHOLIC ACID; TAURINE; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS DISTRESS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER FUNCTION TEST; PERINATAL MORTALITY; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; PRURITUS;

EID: 0031952407     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80207-9     Document Type: Article

References (53)

1. Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O. Changes in serum bile acids concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol. 88:1981;240-245.
2. Reyes H. The enigma of intrahepatic cholestasis of preognancy: lessons from Chile. Hepatology. 2:1982;87-96.
3. Van Dyke RW. The liver in pregnancy. Zakim D, Boyer TD. Hepatology. A Textbook of Liver Disease. 2:1990;1438-1459 WB Saunders, Philadelphia.
4. Reyes H, Gonzalez MC, Ribalta J, Aburto H, Matus C, Schramm G, et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med. 88:1978;487-493.
5. Johnston WG, Baskett TF. Obstetric cholestasis - a 14-year review. Am J Obstet Gynecol. 133:1979;299-301.
6. Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet. 22:1984;91-94.
7. Fisk NM, Storey GNB. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol. 95:1988;1137-1143.
8. Reyes H, Radrigán ME, Gonzalez MC, Latorre R, Ribalta J, Segovia N, et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology. 93:1987;584-590.
9. Laatikainen T. Effect of cholestyramine an phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy. Am J Obstet Gynecol. 132:1978;501-506.
10. Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur J Obstet Gynecol Reprod Biol. 14:1982;153-162.
11. Frezza M, Pozzato G, Chiesa L, Stramentinolo G, Di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methione administration. Hepatology. 4:1984;274-278.
12. Almasio P, Bortolini M, Pagliaro L, Coltorti M. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis. Drugs. 40:1990;111-123. (Suppl).
13. Ribalta J, Reyes H, Gonzalez MC, Iglesias J, Arresse M, Poniachik J, et al. S-Adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology. 13:1991;1084-1089.
14. Hirvioja ML, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gynaecol. 99:1992;109-111.
15. Gonzalez MC, Iglesias J, Tiribelli C, Ribalta J, Reyes H, Hernandez I, et al. Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy [letter]. J Hepatol. 16:1992;241-242.
16. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology. 15:1992;1043-1047.
17. Marpeau L, Chazouillière D, Rhimi Z, Poupon R, Pigne A, Barrat J. Pregnancy-associated idiopathic intrahepatic cholestasis. Hypotheses of physiopathology: a therapeutic case report. Fetal Diagn Ther. 6:1991;120-125.
18. Mazzella G, Rizzo N, Salzetta A, Iamperi R, Bovicelli L, Roda E. Management of intrahepatic cholestasis in pregnancy. Lancet. 338:1991;1594-1595.
19. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez M, Hernandez I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Paumgartner G, Stiehl A, Gerok W. Bile Acids as Therapeutic Agents. 1991;319-322 Kluwer Academic, Dordrecht.
20. Brites D, Poeiras J, Rodrigues C. Colestase intra-hepática da gravidez. Etiopatogénese, prognóstico e terapêutica. Acta Med Port. 7:1994;181-188.
21. Floreani A, Paternoster D, Grella V, Sacco S, Gangemi M, Chiaramonte M. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol. 101:1994;64-65.
22. Davies MH, Dasilva RCMA, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut. 37:1995;580-584.
23. Hofmann AF, Popper H. Ursodeoxycholic acid for primary biliary cirrhosis. Lancet. ii:1987;398-399.
24. Poupon R, Poupon RE, Calmus Y, Chrétien Y, Ballet F, Darni F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis. Lancet. ii:1987;834-836.
25. Leuschner U, Fischer H, Kurtz W, Güldütuna S, Hubner K, Hellsten A, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology. 97:1989;1268-1274.
26. Colombo C, Setchell KDR, Podda M, Crosignani A, Roda A, Curcio L, et al. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr. 117:1990;482-489.
27. Crosignani A, Batterzzati PM, Setchell KDR, Camisasca M, Bertolini E, Roda A, et al. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study. Hepatology. 13:1990;339-344.
28. Balistreri WF, A-Kader HH, Ryckman FC, Whitington PF, Heubi JE, Setchell KDR. Biochemical and clinical response to ursodeoxycholic acid administration in paediatric patients with chronic cholestasis. Paumgartner G, Stiehl A, Gerok W. Bile Acids as Therapeutic Agents. From Basic Science to Clinical Practice. 1991;323-333 Kluwer Academic, Dordrecht.
29. Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology. 16:1992;707-714.
30. Poupon RE, Balkau B, Eschwege E, Poupon R. UDCA-PBC Study Group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med. 324:1991;1548-1554.
31. Mashige F, Imai K, Osuga T. A simple and sensitive assay of bile acids. Clin Chim Acta. 70:1976;79-86.
32. Brites D, Silva R. Doseamento enzimático dos ácidos biliares. Optimização da reacção e valores normais. Rev Port Farm. 36:1985;8-14.
33. Feldmann D, Fenech C, Cuer JF. Evaluation of a sample preparation procedure for bile acids in serum and bile. Clin Chem. 29:1983;1694.
34. Labbé D, Gerhard M-F, Myara A, Vercambre C, Trivin F. High-performance liquid chromatographic determination of tauro- and glyco-conjugated bile acids in human serum. J Chromatogr. 490:1989;275-284.
35. Beke R, De Weerdt GA, Parijs J, Huybrechts W, Barbier F. Separation of conjugated and unconjugated bile acids by thin layer chromatography. Clin Chim Acta. 70:1976;197-199.
36. Goswami SK, Frey CF. Thin-layer chromatographic method for the separation of conjugated deoxycholic acid from conjugated chenodeoxycholic acid. J Chromatogr. 145:1978;147-150.
37. Correia LE, Brites D. Separação, identificação e quantificação dos diferentes ácidos biliares no soro. Rev Port Farm. 36:1985;30-35.
38. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Riely CA, Abell TL. Gastroenterology Clinics of North America. Gastrointestinal and Liver Problems in Pregnancy. 1992;905-921 WB Saunders, Philadelphia.
39. Wojcicka-Jagodzinska J, Kuczynska-Sicinska J, Czajkowski K, Smolarczyk R. Carbohydrate metabolism in the course of intrahepatic cholestasis in pregnancy. Am J Obstet Gynecol. 161:1989;959-964.
40. Ancey P, Saint-Cyr M, Paliard P. Ictère sous contraceptif oral, cholestase gravidique et élévation des transaminases. Presse Méd. 18:1989;1480.
41. Wilson JAP. Intrahepatic cholestasis of pregnancy with marked elevation of transaminases in a Black American. Dig Dis Sci. 32:1987;665-668.
42. Laatikainen T, Hesso A. Determination of serum bile acids by glass capillary gas-liquid chromatography. Clin Chim Acta. 64:1975;63-68.
43. Sjövall K, Sjövall J. Serum bile acids levels in pregnancy with pruritus (bile acids and steroids 158). Clin Chim Acta. 13:1966;207-211.
44. Tikkanen MJ, Adlercreutz H. Recurrent jaundice in pregnancy. Quantitative determination of urinary estriol conjugates, inlcuding studies in pruritus gravidarum. Am J Med. 54:1973;600-604.
45. K Samuelson, Thomassen PA. Radioimmunoassay of serum bile acids in normal pregnancy and in recurrent cholestasis of pregnancy. Acta Obstet Gynecol Scand. 59:1980;417-420.
46. Heikkinen J, Ylöstalo P, Mäentausta O, Jänne O. Bile acids in maternal serum, umbilical cord serum and amniotic fluid of healthy women, women with pruritus and patients with intrahepatic cholestasis of pregnancy. J Obstet Gynaecol. 4:1983;17-20.
47. Bacq Y, Myara A, Brechot M-C, Hamon C, Studer E, Trivin F, Metman E-H. Serum conjugated bile acids profile during intrahepatic cholestasis of pregnancy. J Hepatol. 22:1995;66-70.
48. Laatikainen T, Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol. 50:1977;313-318.
49. Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstet Gynecol. 61:1983;581-587.
50. Roszkowski I, Pisarek-Miedzinska D. Jaundice in pregnancy. II. Clinical course of pregnancy and delivery and condition of neonate. Am J Obstet Gynecol. 101:1968;500-503.
51. Sepulveda WH, Gonzalez C, Cruz MA, Rudolph MI. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol. 42:1991;211-215.
52. Hofmann AF. Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypotheses. Paumgartner G, Stiehl A, Barbara L, Roda E. Strategies for the Treatment of Hepatobiliary Diseases. 1990;13-34 Kluwer Academic, Dordrecht.
53. Zimber A, Zusman I. Effects of secondary bile acids on the intrauterine development in the rat. Teratology. 42:1990;215-224.